Kiniksa Pharmaceuticals, Ltd. , a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide.
Kiniksa Pharmaceuticals stock last closed at $19.73, down 1.3% from the previous day, and has increased 80.35% in one year. It has overperformed other stocks in the Biotechnology industry by 0.85 percentage points. Kiniksa Pharmaceuticals stock is currently +91.74% from its 52-week low of $10.29, and -10.68% from its 52-week high of $22.09.
At the moment, there are 70.62M KNSA shares outstanding. The market value of KNSA is $1.39B. In the last 24 hours, 359,619 KNSA shares were traded.
How to Buy Kiniksa Pharmaceuticals Stock
Not sure how to invest in Kiniksa Pharmaceuticals stock? Here's how.
Choose where to buy Kiniksa Pharmaceuticals stock: You need to choose an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Kiniksa Pharmaceuticals stock.
Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
Deposit money your investment account: Select your payment method and add your details.
Evaluate Kiniksa Pharmaceuticals stock: The Kiniksa Pharmaceuticals ticker symbol is KNSA. Is Kiniksa Pharmaceuticals stock a good investment? Should you buy shares of KNSA? How do KNSA's underlying business fundamentals look? Do top analysts think Kiniksa Pharmaceuticals is a good buy? Why has KNSA's stock price moved recently? (Hint: Our stock analysis website can help you understand if KNSA is a good stock to buy).
Place your KNSA purchase: Decide if you will purchase KNSA shares at the current market price or use a limit order to buy KNSA shares at a given price.
Keep tabs on your KNSA investment: Create a watchlist to important notifications about your position in Kiniksa Pharmaceuticals stock.
Step 1: Choose where to buy Kiniksa Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy KNSA stock.
A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our research, eToro is the best stock brokerage. eToro gives you:
You can invest in stocks with 0% commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to world markets: From Technology to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal information so you are able to invest in KNSA stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Kiniksa Pharmaceuticals stock
After you have chosen the best place to buy Kiniksa Pharmaceuticals stock, it's critical to analyze their stock prior to buying, so you can understand the risk as well as the opportunity.
Kiniksa Pharmaceuticals shares quick numbers
KNSA Price
$19.73
1w %
-0.35%
1y %
80.35%
5y %
11.41%
P/E
98.65x
P/B
3.17x
P/S
5.11x
PEG
N/A
Revenue
$270.26M
Earnings
$14.08M
Fore. Rev. Growth
29.61%
Fore. Earn. Growth
N/A
Market Cap
$1.39B
Next Earnings
Apr 30, 2024
Next Dividend
N/A
Fundamentals of KNSA
WallStreetZen was designed to help part-time investors do better fundamental analysis quickly.
Last year, KNSA earnings were $14.08M. Over the last one years, KNSA's earnings have gone up by -92.42% per year. This was slower than the Biotechnology industry average of 15.66%.
Last year, KNSA revenue was $270.26M. In the last two year, KNSA's revenue has increased by 164.8% per year. This was faster than the Biotechnology industry average of 29.51%.
No, Kiniksa Pharmaceuticals doesn't provide an income stream by paying out dividends.
What others are saying about KNSA
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Place your KNSA purchase
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are usually fine for most investors.
Limit order: A limit order allows you to buy or sell a stock at a specific price (or better). If you want to ensure you're buying or selling at an exact price, place a limit order.
Click the Open Trade button and your broker will execute the order.
If you want more info about buying stocks on eToro, click the how to video below:
How much does it cost to buy one Kiniksa Pharmaceuticals share?
As of Mar 28, 2024, it costs $19.73 to buy one share of Kiniksa Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $9, you can buy 0.456 shares of KNSA.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.